Biotechnology News

Discussions with FDA advance toward expected marketing authorization for GraftAssureDxFDA completes current portion of substantive review in a timely mannerFavorable Medicare reimbursement policy...

Envudeucitinib long-term Phase 3 data for treatment of plaque psoriasis, delivering highest reported PASI 100 Skin Clearance among oral therapies

MALVERN, Pa., Aug. 10, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today...

Completed acquisition of Ouro Medicines with Gilead Sciences to advance potential first and best-in-class T-cell engager Forecast at least €1.6B of cash remaining after funding portfolio to first...

Overname van Ouro Medicines samen met Gilead Sciences afgerond om potentiële first- en best-in-class T-cel-engager verder te ontwikkelen Ten minste €1,6 miljard aan liquide middelen verwacht over te...

SAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for...

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

WATERTOWN, Mass., Aug. 10, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation...

Company announcement no. 29 – 2610 August 2026 NTG Nordic Transport Group publishes interim report for H1 2026The interim report for H1 2026 is enclosed. In connection with publication of the...

Six new Genome BC supported projects use integrated genomic and health data to explore earlier diagnosis, personalized care and better outcomes.